Media coverage
6
Media coverage
Title Dec 10, 2018, 2:00 am EST Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Boston Business Journal Country/Territory United States Date 10/12/18 URL https://www.bizjournals.com/boston/businesswire/press_releases/Massachusetts/2018/12/10/20181209005013 Persons Jeremiah Faith Title Dec 10, 2018, 2:00 am EST Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Boston Business Journal Country/Territory United States Date 10/12/18 URL https://www.bizjournals.com/boston/businesswire/press_releases/Massachusetts/2018/12/10/20181209005011 Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Tullahoma News Country/Territory United States Date 10/12/18 URL https://www.tullahomanews.com/news/business/bristol-myers-squibb-and-vedanta-biosciences-announce-a-new-clinical/article_ef9518c9-4d62-5b49-8ed5-5c441a37de32.html Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Tullahoma News Country/Territory United States Date 10/12/18 URL https://www.tullahomanews.com/news/business/bristol-myers-squibb-and-vedanta-biosciences-announce-a-new-clinical/article_f0faa9b5-2204-5d8f-a4b0-1d44ad90b27d.html Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet VB Profiles Country/Territory United States Date 10/12/18 URL https://www.vbprofiles.com/press_releases/5c0e172cb9abe47f73268fda Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet VB Profiles Country/Territory United States Date 10/12/18 URL https://www.vbprofiles.com/press_releases/5c0e1731b9abe47f73268fdb Persons Jeremiah Faith